The effects of pirenzepine (P), a cholinergic muscarinic antagonist, on growth hormone (GH) and prolactin (PRL) response to dermorphin (D) were studied in a group of 7 healthy men. D produced clear elevations in GH and PRL levels. P completely blocked the GH-releasing activity of D, whereas it did not alter the PRL-releasing activity. These results indicate that GH-releasing action of D is mediated via the central cholinergic nervous system in man
Abstract Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone (GH) release a...
The intravenous administration of 250 micrograms D-Ala2-MePhe4-Met-enkephalin-O-ol (DAMME) caused a ...
Two new related heptapeptides (dermorphins) with potent central and peripheral opiate-like activity ...
It is well established that compounds that modify dopaminergic and cholinergic activity in man may i...
In view of the important role played by the cholinergic system in the neural regulation of growth ho...
In five healthy normal male volunteers, pretreatment with the cholinergic muscarinic antagonist pire...
Ghrelin secretion has been reportedly increased by fasting and energy restriction but decreased by f...
Ghrelin secretion has been reportedly increased by fasting and energy restriction but decreased by f...
The effects of cholinergic muscarinic receptor antagonist pirenzepine on the GHRH-induced GH release...
Previous studies have shown that corticotropin-releasing hormone (CRH) is capable of inhibiting grow...
The secretion of various pancreatic hormones (insulin, glucagon and pancreatic polypeptide) is affec...
To investigate the influence of the cholinergic system on the modulation of the circulating levels o...
We have studied the effect of increased cholinergic tone on the GH response to growth hormone-releas...
We have recently shown that dermorphin (D), a new potent opioid peptide (H-Tyr-D-Ala-Phe-Gly-Tyr-Pro...
Dermorphins (D) are heptapeptides (H-Tyr-D-Ala-Phe-Gly-Tyr-X-Ser-NH2; X, Pro or Hyp) with powerful c...
Abstract Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone (GH) release a...
The intravenous administration of 250 micrograms D-Ala2-MePhe4-Met-enkephalin-O-ol (DAMME) caused a ...
Two new related heptapeptides (dermorphins) with potent central and peripheral opiate-like activity ...
It is well established that compounds that modify dopaminergic and cholinergic activity in man may i...
In view of the important role played by the cholinergic system in the neural regulation of growth ho...
In five healthy normal male volunteers, pretreatment with the cholinergic muscarinic antagonist pire...
Ghrelin secretion has been reportedly increased by fasting and energy restriction but decreased by f...
Ghrelin secretion has been reportedly increased by fasting and energy restriction but decreased by f...
The effects of cholinergic muscarinic receptor antagonist pirenzepine on the GHRH-induced GH release...
Previous studies have shown that corticotropin-releasing hormone (CRH) is capable of inhibiting grow...
The secretion of various pancreatic hormones (insulin, glucagon and pancreatic polypeptide) is affec...
To investigate the influence of the cholinergic system on the modulation of the circulating levels o...
We have studied the effect of increased cholinergic tone on the GH response to growth hormone-releas...
We have recently shown that dermorphin (D), a new potent opioid peptide (H-Tyr-D-Ala-Phe-Gly-Tyr-Pro...
Dermorphins (D) are heptapeptides (H-Tyr-D-Ala-Phe-Gly-Tyr-X-Ser-NH2; X, Pro or Hyp) with powerful c...
Abstract Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone (GH) release a...
The intravenous administration of 250 micrograms D-Ala2-MePhe4-Met-enkephalin-O-ol (DAMME) caused a ...
Two new related heptapeptides (dermorphins) with potent central and peripheral opiate-like activity ...